Public Health

ERG public health professionals support clients in strengthening the health, safety, and well-being of people throughout the United States and beyond. We collect, research, and analyze empirical data to evaluate the implications of all types of public health concerns, from unmet medical needs to food safety to exposure to environmental contaminants. Whether examining health disparities or conceptualizing incentives to encourage innovation, ERG health professionals consistently consider how emerging patterns and trends may influence the problem and contribute to evidence-based solutions. Based on the evidence, we help design, implement, and evaluate programs and policies aimed at tackling public health issues as effectively as possible. In doing so, we use or innovate approaches to help our clients generate meaningful results grounded in principles of equity, inclusion, transparency, and accountability. To propagate solutions, we collaborate with ERG communication specialists to develop health outreach and education programs that empower clinicians, community workers, the public, and others to improve health outcomes within their sphere of influence. Throughout our work, we combine sound scientific principles with innovative, forward-looking thinking to anticipate and address both current and potential future concerns.

Risk Assessment
  • Hazard analysis
  • Fate and transport modeling
  • Exposure assessment
  • Sensitive population assessment
  • Toxicological evaluation
  • Dose-response analysis
  • Health outcome data review
  • Health indicator development and tracking
  • Health risk characterization
  • Uncertainty analysis
Epidemiology
  • Biomonitoring
  • Epidemiologic study design
  • Environmental epidemiology
  • Infectious disease epidemiology
  • Wastewater-based epidemiology
Health Policy
  • Patient-focused drug development
  • Prescription drug pricing
  • Antimicrobial resistance
  • Clinical trial costs
  • Medical product supply chains
  • Addictive substance misuse (tobacco, opioids, etc.)
  • Medication administration safety
  • Emergency preparedness and response
Health Economics
  • Benefit-cost analysis
  • Cost-effectiveness analysis
  • Statistical/economic modeling and analysis, including microsimulation modeling
  • Health outcomes research
  • Health policy evaluations
  • Uncertainty/sensitivity analysis
Program Evaluation
  • Engagement with all interested parties
  • Needs analysis, outcomes assessment, and strategic planning
  • Program description and logic models
  • Focused evaluation and methodology design
  • Multi-modal data collection (surveys, focus groups, and expert panels) and analysis
  • Extraction and analysis of administrative data
  • Credible, inclusive, evidence-based assessment of implementation, effectiveness, efficiency, cost-effectiveness, and attributions
  • Life cycle studies
Health Equity
  • Equity-centered data collection, analysis, and planning
  • Health disparities, historical root causes, and ongoing dynamics
  • Social determinants of health
  • Accessible connection, collaboration, and partnership with people with lived experience
  • Participatory research
  • Cultural and identity awareness
  • Workforce training and development
Communication and Education
  • Outreach and inclusion (all interested parties)
  • Public health campaigns (all audiences)
  • Virtual and in-person education and training (all audiences)
  • Risk communication
Example Topics
  • Health and wellness
  • Injury and illness prevention
  • Chemicals of concern (e.g., PFAS)
  • Food safety
  • Pharmaceuticals and biologics (e.g., antimicrobials, generics, biosimilars, vaccines)
  • Medical devices
  • Tobacco and substance misuse
  • Circular economy and materials management

Projects

photo of magnified COVID-19 cell
Wastewater COVID-19 Surveillance to Prevent Outbreaks

New Mexico Environment Department

Photo of a shower head spraying water
Shower and Household Water-Use Exposure (SHOWER) Model

Agency for Toxic Substances and Disease Registry

PFAS Information for Clinicians Newly Updated
PFAS Information for Clinicians

Agency for Toxic Substances and Disease Registry

screenshot image of training presentation from Environmental Justic and social Determinants of Health
Environmental Health Equity Training

Massachusetts Department of Public Health

diagram of impact of COVID-19 on Domestic Violence
PHIT Violence Report

Massachusetts Department of Public Health

Photo of packaged pills
Survey of Pharmaceutical Manufacturers, Processors, and Packagers

U.S. Food and Drug Administration

wastewater monitoring tanks
Monitoring Wastewater for Opioid and Other Drug Use

Water Research Foundation

Photo of a busy airport terminal with directional signs to the gates
Capturing Airport Lessons Learned from COVID-19

Airport Cooperative Research Program

Photo of diversified team of people around a table in an office setting
Development of a Roadmap for Equity-Centered Data Strategic Planning

Massachusetts Department of Public Health

Photo of Clinical Trial use medication and syringe laying on top of a medical form
Evaluating the Potential Impacts of Different Clinical Trial Strategies on Drug, Preventive Vaccine, and Therapeutic Complex Medical Device Development

U.S. Department of Health and Human Services

Photo of a robotic hand
Modeling the Cost of Developing a Complex Therapeutic Medical Device for the U.S. Market

U.S. Department of Health and Human Services

Workers wearing full protective gear while processing chicken in a food processing facility
COVID-19 Food Facility Assessment Survey Tool

Massachusetts Department of Public Health

Photo of various pills loosely piled on top of a stack of cash
Cost of Generic Drug Development and Approval

U.S. Department of Health and Human Services

photo of training manual on a table along with bottles of medication and a glass of water
Evaluation and Recommendations for the Massachusetts Medication Administration Program (MAP)

Massachusetts Department of Public Health

Close-up of FDA-regulated medication pills on a mirror
Assessing the Effectiveness of an Innovative FDA Drug Review Program

U.S. Food and Drug Administration

Worker wearing a gas mask and visor inspects machinery in an industrial setting
Assessing Chemicals of Potential Concern Under TSCA

U.S. Environmental Protection Agency

Air monitoring device situated in a yard just outside a home
Measuring Community Exposures to Fill Critical Data Gaps

Centers for Disease Control and Prevention


Service Area Leads

Headshot of Clifton Dassuncao

Often the most vulnerable communities are disproportionately impacted by environmental hazards. In my work, I strive to offer solutions that help address environmental injustices and improve public health for all communities.

Clifton Dassuncao

Calvin Franz

At ERG, our economic projects often take us into uncharted territory where standard, regularly collected data are few or unavailable and the analytic path to answer our client’s questions is not obvious. This is exactly where I like to be! I find it deeply satisfying to explore new territory, address unique challenges, and use my expertise and creativity to develop approaches that provide meaningful, defensible results.

Calvin Franz

Naida Gavrelis

I am passionate about doing all we can to protect people’s health and well-being and the environment in which we live. I have devoted my career to addressing health risks encountered in our communities and workplaces. I strive to solve problems using common sense and sound science.

Naida Gavrelis

Arlene Levin

I was thrilled when I started working for ERG and found that I could apply my passion for environmental and occupational health by working for government agencies that promote and protect the health of individuals, workers, and the environment. This nexus has allowed me to pursue incredibly interesting work across myriad health-related topics and to help my clients plan, develop, and implement successful programs and initiatives.

Arlene Levin

Photo of Will Morgan

Environmental science—especially figuring out how and where chemicals move through the environment—is continually challenging and endlessly fascinating. It’s extremely rewarding to know that our work helps protect human health and make sites safer for future generations.

Will Morgan

Lou Nadeau

Agencies tend to manage what can be readily measured, but with a large toolbox of analytical and data collection techniques and some creativity, so much more is possible! I am proud and inspired to apply my program evaluation and economic valuation expertise to help agencies manage better—by providing them with valid, reliable data to enhance decision-making and by effectively communicating this information to my clients, their stakeholders, and upper management.

Lou Nadeau

Valerie Overton

In today’s world, pioneering innovative solutions requires collaboration between all of us: the people, interested parties, subject experts, information technologists, communicators, and others. I’m proud to be part of an organization that is built around an inclusive approach to progress. ERG empowers us to conceive forward-looking ideas and develop new solutions to meet our present and future needs.

Valerie Overton

Aylin Sertkaya

Economic analysis has been my field ever since my early 20s, when I first discovered its complexities, potential, and power. At ERG, I’ve had the good fortune to work with great colleagues and clients to research issues and develop solutions for a wide variety of highly consequential public health questions. It has been a consistent joy to do work that is not only impactful but also a path of continuous learning and deepening.

Aylin Sertkaya

John Wilhelmi

Clean air, safe workplaces, a stable climate for generations to follow—these are just some of the ideals that motivate my daily work. I strive to bring the best available science to our nation’s current and emerging environmental health and occupational safety issues.

John Wilhelmi